HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nicole Lefrançois Selected Research

Sirolimus (Rapamycin)

11/2010Efficacy and safety of de novo or early everolimus with low cyclosporine in deceased-donor kidney transplant recipients at specified risk of delayed graft function: 12-month results of a randomized, multicenter trial.
7/2009Incidence of delayed graft function and wound healing complications after deceased-donor kidney transplantation is not affected by de novo everolimus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Nicole Lefrançois Research Topics

Disease

5Delayed Graft Function
11/2010 - 05/2007
1Leptospirosis
06/2014
1Hemorrhage
06/2014
1Cytomegalovirus Infections (Inclusion Disease)
06/2010
1Anemia
12/2008
1Diabetes Mellitus
07/2007
1Hepatitis C
07/2007
1Neoplasms (Cancer)
04/2006

Drug/Important Bio-Agent (IBA)

2EverolimusFDA Link
11/2010 - 07/2009
2Sirolimus (Rapamycin)FDA Link
11/2010 - 07/2009
2CreatinineIBA
06/2009 - 05/2007
1Hemostatics (Antihemorrhagics)IBA
06/2014
1Heparin (Liquaemin)FDA LinkGeneric
06/2014
1Cyclosporine (Ciclosporin)FDA LinkGeneric
11/2010
1Calcineurin InhibitorsIBA
11/2010
1TOR Serine-Threonine KinasesIBA
11/2010
1Tacrolimus (Prograf)FDA LinkGeneric
06/2010
1Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA
06/2010
1Glucose (Dextrose)FDA LinkGeneric
07/2007

Therapy/Procedure

3Therapeutics
06/2014 - 06/2010
3Kidney Transplantation
07/2009 - 07/2007
3Transplantation
07/2009 - 04/2006